Equitable Access to Clinical Trials: How Do We Achieve It?
Am Soc Clin Oncol Educ Book
; 43: e389838, 2023 May.
Article
en En
| MEDLINE
| ID: mdl-37146264
ABSTRACT
The mismatch between the study populations participating in oncology clinical trials and the composition of the targeted cancer population requires urgent amelioration. Regulatory requirements can mandate that trial sponsors enroll diverse study populations and ensure that regulatory revue prioritizes equity and inclusivity. A variety of projects directed at increasing accrual of underserved populations to oncology clinical trials emphasize best practices broadened eligibility requirements for trials, simplification of trial procedures, community outreach through patient navigators, decentralization of clinical trial procedures and institution of telehealth, and funding to offset costs of travel and lodging. Substantial improvement will require major changes in culture in the educational and professional practice, research, and regulatory communities and will require major increases in public, corporate, and philanthropic funding.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias
Tipo de estudio:
Guideline
Idioma:
En
Revista:
Am Soc Clin Oncol Educ Book
Año:
2023
Tipo del documento:
Article